trending Market Intelligence /marketintelligence/en/news-insights/trending/uWheRCDFMUC4dk0IQGDrcg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Stereotaxis announces $25M private placement

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Stereotaxis announces $25M private placement

Stereotaxis Inc. said it is looking to raise $25 million via the sale of securities to certain institutional investors.

The St. Louis-based healthcare technology company will sell 12.2 million shares of common stock and convertible preferred stock to select healthcare-focused and growth-oriented institutional investors at $2.05 apiece. The financing will be led by Redmile Group and also Opaleye Management and Parkman Healthcare Partners.

Cowen is the exclusive placement agent for the private placement.

"A financing was not necessary to accomplish our strategic goals but will enhance our commercial growth initiatives and a second wave of innovation in electrophysiology and beyond," Stereotaxis Chairman and CEO David Fischel said in a statement.

Stereotaxis develops robotic technologies to treat cardiac arrhythmias, a heart condition characterized by an irregular heartbeat.